Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 3.47% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.97% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 13.19% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 9.80% |
| 10 | Standard Biotools | 344.96 Mn | -110.22 Mn | 11.31 Mn | -11.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.89% |
| Dec 31, 2025 | -9.09% |
| Sep 30, 2025 | -7.94% |
| Jun 30, 2025 | -5.97% |
| Mar 31, 2025 | 16.32% |
| Dec 31, 2024 | -6.69% |
| Sep 30, 2024 | 13.24% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | 23.49% |
| Dec 31, 2023 | 11.32% |
| Sep 30, 2023 | 48.25% |
| Jun 30, 2023 | 46.09% |
| Mar 31, 2023 | 45.34% |
| Dec 31, 2022 | 47.12% |
| Sep 30, 2022 | 46.84% |
| Jun 30, 2022 | 48.68% |
| Mar 31, 2022 | 49.84% |
| Dec 31, 2021 | 47.00% |
| Sep 30, 2021 | 43.62% |
| Jun 30, 2021 | 38.54% |